期刊文献+

西坦类药物研究进展 被引量:10

Research Development on Recetam-Family Drugs
下载PDF
导出
摘要 西坦类药物有防治认知功能障碍、抗癫痫和镇痛等作用,具有作用机制独特、疗效显著、不良反应发生率低等优点,目前已成为临床的常用药物。通过对西坦类药物进行总结,并从作用机制、临床应用等方面对其研究进展进行归纳,将有助于西坦类药物的进一步发展。 The racetam-family drugs have the effect of the prevention and treatment of the cognitive dysfunction, anti-epilepsy, analgesia and so on. Those drugs have the advantages of unique action mechanism,remarkable curative effect and low side-effects,and at present they have become commonly used drugs in clinic. Summarizing the racetam-family drugs and concluding their researches in the aspects of action mechanism and clinical application will contribute to the further development of the recetam-family drugs.
出处 《中国药业》 CAS 2015年第1期4-7,共4页 China Pharmaceuticals
基金 辽宁省教育厅基金项目 项目编号:L2012146
关键词 西坦类药物 认知功能障碍 抗癫痫 镇痛 研究进展 racetam-family drugs cognitive deficits antiepileptic analgesic research development
  • 相关文献

参考文献27

  • 1Malykh AG, Sadaie DR. Piracetam and Piracetam - Like Drugs : from basic science to novel clinical applications to CNS disorders [ J ]. Drugs, 2010,70 (3) :287 -312.
  • 2Marisco PC, Carvaiho FB, Rosa MM, et al. Piracetam Prevents Scopo- lamine - Induced Memot'y Impairment and Decrease of NTPDasc, 5' -Nu- cleotidase and Adenosine Deaminase Activities[J]. Neurochemical Re- search,2013,38(8): 1 704 - 1 714.
  • 3Diana S, Woodruff P. Preclinical experiments on cognition enhancement in Alzheimer' s disease: Drugs affecting nicotinic acetylcholine receptors[J ]. Drug Development Research, 2002,56 (3) : 335 - 346.
  • 4Mueller R, Li YX, Hampson A, et al. Benzoxazinones as potent positive al- losteric AMPA receptor modulators Part I[J ] . Bioorganic and Medicinal Chemistry Letters,2011,21 (13): 3 923 -3 926.
  • 5Claus JJ, Ludwig C, Mohr E, et al. Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiraeetaml J] . Neurology, 1991,41 (4): 570 - 574.
  • 6Firstova YY, Abaimov DA, Kapitsa IG, et al. 'He eftcts of scopolamine and the nootropic drug phenotropil on rat brain neurotransmitter receptor during testing of' the conditioned passive avoidance task[J ]. Neurochemical Journal,2011,28 (2): 130 - 141.
  • 7Fulvio G, Dina M, Maria NR, et al. Design and study of piracetam - like nootropics, controversial members of the pmblenmtic class of cognition- enhancing drugs [ J]. Current Pharmaeeutical Design, 2002, 8 (2) : 125 - 138.
  • 8Lu XC, Dave .IR, Chen ZY, et al. Nefiraeetam attenuates post-is- chemic noneonvulsive seizures in rats and protects neuronal cell death induced by veratridine and glutamate[J]. Life Sciences,2013, 92(22): I 055 - 1 063.
  • 9Butler DE, Leonard JD, Caprathe BW, et al. Amnesia - reversal activity of a series of cyclic imides[J]. Journal of Medicinal Chemistry, 1987,30(3): 498 -503.
  • 10Takashina K. MKC - 231, a choline uptake enhancer: Mode of aetion of MKC-231 in the enhancement o high-affinity choline uptake[J]. J Neural Transm, 2008,115 (7) : 1 037 - 1 046.

同被引文献75

引证文献10

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部